Pharma ETFs Set To Benefit Post Strong Q3 Earnings

Total earnings of the 79.7% of the entire healthcare market capitalization that has reported so far are up 7.1% on revenue growth of 8.2%. The earnings and revenue growth rates seem to be the fourth highest among all the sectors. Earnings and revenue beat ratios of 80.6% and 86.1%, respectively also appear strong.

Most industry bigwigs delivered encouraging results, either beating on earnings or revenues or both and also raised revenue or earnings guidance or both. Let’s delve into a few of them:

Earnings in Focus

Johnson and Johnson

The world's biggest healthcare products maker continued its long streak of earnings beat. It also outpaced revenue estimates. Earnings per share came in at $2.12, 12 cents ahead of the Zacks Consensus Estimate and 3.4% higher than the year-ago quarter. Revenues grew 1.9% year over year to $20.7 billion and edged past the Zacks Consensus Estimate of $20.1 billion. For 2019, Johnson & Johnson raised its sales forecast to $81.8-$82.3 billion from $80.8-$81.6 billion, which represents 0.2%-0.7% year-over-year growth, on robust demand for its cancer drugs. It also upped its earnings per share guidance to $8.62-$8.67 from $8.53-$8.63, representing year-over-year growth of 5.4-6%.


Earnings per share of 75 cents were 12 cents above the Zacks Consensus Estimate and revenues of $12.68 billion also edged past the consensus mark of $12.15 billion. On a year-over-year basis, earnings per share and revenues declined 2% and 5%, respectively. For 2019, the U.S. drug giant revised sales guidance to $51.2-$52.2 billion from $50.5-$52.5 billion and earnings per share to $2.94-$3.00 from $2.76-$2.86.


Earnings per share of $1.51 surpassed the Zacks Consensus Estimate of $1.25 and also improved 27% from the year-ago quarter. Moreover, revenues grew 15% year over year to $12.4 billion, edging past the consensus mark of $11.7 billion. Merck increased its revenue projection from $45.2-$46.2 billion to $46.5-$47 billion for this year and earnings per share view from $4.84-$4.94 to $5.12-$5.17.

1 2 3
View single page >> |

Disclosure: contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any specific ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.